Patent application number | Description | Published |
20090027831 | Lithium Ion Capacitor - It is to provide a lithium ion capacitor having a high energy density, a high output density, a large capacity and high safety. | 01-29-2009 |
20090135549 | LITHIUM ION CAPACITOR - A lithium ion capacitor includes a positive electrode including a positive electrode active material capable of reversibly doping either one or both of a lithium ion and an anion, a negative electrode including a negative electrode active material capable of reversibly doping a lithium ion, and a non-protonic organic solvent electrolytic solution of a lithium salt as an electrolytic solution. The lithium ion is doped to either one or both of the negative electrode and positive electrode so that the positive electrode potential after the positive electrode and negative electrode are short-circuited is 2.0 V or less. A surface of the negative electrode is covered with a polymer. | 05-28-2009 |
20090154064 | Lithium ion capacitor - A lithium ion capacitor including a positive electrode, a negative electrode, and an aprotic organic solvent solution of a lithium salt as an electrolytic solution. The positive electrode active material is capable of reversibly supporting lithium ions and/or anions, the negative electrode active material is capable of reversibly supporting lithium ions and anions, and the potentials of the positive electrode and the negative electrode are at most 2.0 V after the positive electrode and the negative electrode are short-circuited. The positive electrode and the negative electrode are alternately laminated with a separator interposed therebetween to constitute an electrode unit, the cell is constituted by at least two such electrode units, lithium metal is disposed between the electrode units, and lithium ions are preliminarily supported by the negative electrode and/or the positive electrode by electrochemical contact of the lithium metal with the negative electrode and/or the positive electrode. | 06-18-2009 |
20090161296 | LITHIUM ION CAPACITOR - A lithium ion capacitor includes a positive electrode, a negative electrode, and a non-protonic organic solvent electrolytic solution of a lithium salt. A positive electrode active material is a material capable of reversibly doping a lithium ion and/or an anion. A negative electrode active material is a material capable of reversibly doping a lithium ion. The lithium ion is doped in advance to either one or both of the negative electrode and the positive electrode so that a positive electrode potential after the positive electrode and the negative electrode are short-circuited is 2.0 V (relative to Li/Li | 06-25-2009 |
20090174986 | Lithium ion capacitor - It is to provide a lithium ion capacitor having a high capacity retention at the time of continuous charge at a high temperature and excellent in durability. | 07-09-2009 |
20100128415 | LITHIUM ION CAPACITOR - A lithium ion capacitor includes a positive electrode made of a material capable of reversibly carrying either one or both of a lithium ion and an anion, a negative electrode made of a material capable of reversibly carrying a lithium ion, and an electrolytic solution made of a non-protonic organic solvent electrolytic solution of a lithium salt. A negative electrode active material is non-graphitizable carbon having a ratio of number of hydrogen atoms to number of carbon atoms of zero or more and less than 0.05. The lithium ion is doped in advance to either one or both of the negative electrode and the positive electrode so that a negative electrode potential when a cell is discharged to a voltage one half a charging voltage of the cell is 0.15 V or less relative to a lithium ion potential. | 05-27-2010 |
Patent application number | Description | Published |
20090264399 | HETEROCYCLIC JANUS KINASE 3 INHIBITORS - The invention relates to compound of the formula (I) or its salt, wherein —R | 10-22-2009 |
20090270376 | HETEROCYCLIC JANUS KINASE 3 INHIBITORS - The present invention provides a compound of formula (I) having an excellent JAK3 inhibition activity and being useful as an active ingredient of an agent for treating and/or preventing various immune diseases including autoimmune diseases inflammatory diseases, and allergic diseases. The compound according to the present invention has an inhibition activity against JAK3 and is thus useful as an active ingredient of an agent for treating or preventing diseases caused by undesirable cytokine signal transmission (e.g., rejection during organ/tissue transplantation, autoimmune diseases, multiple sclerosis, rheumatoid arthritis, psoriasis, asthma, atopic dermatitis, Alzheimer's disease, and atherosclerotic disease), or diseases caused by abnormal cytokine signal transmission (e.g., cancer and leukemia). | 10-29-2009 |
20100105661 | CONDENSED PYRIDINE COMPOUND - The present invention provides a compound having excellent JAK3 inhibitory activity and being useful as an active ingredient of an agent for treating and/or preventing various immune diseases including autoimmune diseases, inflammatory diseases, and allergic diseases. | 04-29-2010 |
20110039822 | HETEROCYCLIC JANUS KINASE 3 INHIBITORS - The present invention provides a compound having an excellent JAK3 inhibition activity and being useful as an active ingredient of an agent for treating and/or preventing various immune diseases including autoimmune diseases, inflammatory diseases, and allergic diseases. | 02-17-2011 |
20110230467 | 4,6-DIAMINONICOTINAMIDE COMPOUND - [Problem] The present invention provides a 4,6-diaminonicotinamide compound which is useful as an active ingredient of a pharmaceutical composition, in particular, a pharmaceutical composition for treating diseases caused by undesirable and/or abnormal cytokine signal transduction. | 09-22-2011 |
20120034250 | CONDENSED PYRROLOPYRIDINE DERIVATIVE | 02-09-2012 |